All articles
Does Mounjaro® Cause Headaches? Causes, Treatment, & More
Reading time:
5 min
Weight loss

Get expert guidance and a personalized care plan designed around you.
More on Mounjaro® and Weight Management
Access a weight loss plan tailored just for you with Mochi Health. From GLP-1 medications to ongoing support from obesity medicine specialists, we offer everything you need for a healthier tomorrow. Membership includes virtual visits with a Mochi provider, unlimited appointments with a registered dietitian, an online support group, access to sleep apnea testing, cognitive behavioral therapy for insomnia, genetic testing, and labs and scans. Your insurance coverage affects the pricing of brand-name medications, but Mochi Health offers compounded alternatives for your convenience and budget. Get compounded semaglutide and tirzepatide delivered straight to your door, ensuring you access effective treatments at an affordable price. Find out if you're eligible to join today.
References:
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A; SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4. PMID: 35658024.
Mounjaro® Compared to Other T2D Medicines | Mounjaro® (Tirzepatide), Eli Lilly and Company, Mounjaro®.lilly.com/what-is-mounjaro/t2d-competitors.
Jensen R. H. (2018). Tension-Type Headache - The Normal and Most Prevalent Headache. Headache, 58(2), 339–345. https://doi-org.offcampus.lib.washington.edu/10.1111/head.13067
Ashina, S., Mitsikostas, D. D., Lee, M. J., Yamani, N., Wang, S. J., Messina, R., Ashina, H., Buse, D. C., Pozo-Rosich, P., Jensen, R. H., Diener, H. C., & Lipton, R. B. (2021). Tension-type headache. Nature reviews. Disease primers, 7(1), 24. https://doi-org.offcampus.lib.washington.edu/10.1038/s41572-021-00257-2
Islam, M. R., & Nyholt, D. R. (2022). Glucose-Related Traits and Risk of Migraine-A Potential Mechanism and Treatment Consideration. Genes, 13(5), 730. https://doi.org/10.3390/genes13050730
Hufnagl, K. N., & Peroutka, S. J. (2002). Glucose regulation in headache: implications for dietary management. Expert review of neurotherapeutics, 2(3), 311–317. https://doi.org/10.1586/14737175.2.3.311
Del Moro, L., Rota, E., Pirovano, E., & Rainero, I. (2022). Migraine, Brain Glucose Metabolism and the "Neuroenergetic" Hypothesis: A Scoping Review. The journal of pain, 23(8), 1294–1317. https://doi.org/10.1016/j.jpain.2022.02.006
Gutzwiller, J. P., Tschopp, S., Bock, A., Zehnder, C. E., Huber, A. R., Kreyenbuehl, M., Gutmann, H., Drewe, J., Henzen, C., Goeke, B., & Beglinger, C. (2004). Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men. The Journal of clinical endocrinology and metabolism, 89(6), 3055–3061. https://doi-org.offcampus.lib.washington.edu/10.1210/jc.2003-031403
Lyngberg, A. C., Rasmussen, B. K., Jørgensen, T., & Jensen, R. (2005). Prognosis of migraine and tension-type headache: a population-based follow-up study. Neurology, 65(4), 580–585. https://doi-org.offcampus.lib.washington.edu/10.1212/01.wnl.0000172918.74999.8a
This post was written by our team of health writers for informational purposes only and does not constitute medical advice. Always consult your doctor or healthcare provider for personalized guidance regarding your health. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® and their delivery device are registered trademarks. Mochi Health is a telehealth clinic that offers prescriptions for these products by medical necessity only as determined by a licensed health provider.
Share this post
Weight loss
More articles
















